|
|
|
11-50 employees
View all
|
|
Biotechnology
|
|
Ole Maaløes Vej 3, Copenhagen, DK
|
|
Hemab Therapeutics ApS is an emerging biotech company supported by Novo Holdings A/S with the aim of developing novel treatments for rare and underserved bleeding disorders. Based in Copenhagen, the company is led by a team of drug developers and scientists with deep expertise in haemophilia. Hemab has exclusive licences to state-of-the-art antibody technologies from both Novo Nordisk A/S and Genmab A/S.
|
Hemab Therapeutics Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
75.00%
|
The widely used Hemab Therapeutics email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.
To contact Hemab Therapeutics customer service number in your country click here to find.
Kathryn Zwetchkenbaum is the CEO of Hemab Therapeutics. To contact Kathryn Zwetchkenbaum email at [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.